# Active Clearance Technology (ACT) Registry

> **NCT02682849** · — · COMPLETED · sponsor: **John M. Stulak** · enrollment: 500 (actual)

## Conditions studied

- Retained Blood Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02682849
- **Lead sponsor:** John M. Stulak
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-10
- **Primary completion:** 2018-05
- **Final completion:** 2020-03
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2020-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02682849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02682849, "Active Clearance Technology (ACT) Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02682849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*